C. Ressayre-Djaffer

486 total citations
8 papers, 80 citations indexed

About

C. Ressayre-Djaffer is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, C. Ressayre-Djaffer has authored 8 papers receiving a total of 80 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 7 papers in Hematology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in C. Ressayre-Djaffer's work include Hemoglobinopathies and Related Disorders (7 papers), Iron Metabolism and Disorders (6 papers) and Pharmacological Effects and Toxicity Studies (2 papers). C. Ressayre-Djaffer is often cited by papers focused on Hemoglobinopathies and Related Disorders (7 papers), Iron Metabolism and Disorders (6 papers) and Pharmacological Effects and Toxicity Studies (2 papers). C. Ressayre-Djaffer collaborates with scholars based in France, Italy and United States. C. Ressayre-Djaffer's co-authors include J. Ford, B. Rabault, Norbert Gattermann, Paul Swerdlow, Mohamed Béjaoui, Brigitta U. Mueller, Leyla Ağaoğlu, Herbert Opitz, B. Files and Maria Domenica Cappellini and has published in prestigious journals such as Blood and Leukemia Research.

In The Last Decade

C. Ressayre-Djaffer

8 papers receiving 75 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Ressayre-Djaffer France 7 78 76 24 6 3 8 80
Cynthia Gauger United States 4 37 0.5× 28 0.4× 12 0.5× 2 0.7× 6 43
Aurélie Stanislas France 4 28 0.4× 27 0.4× 15 0.6× 1 0.3× 4 33
Venkatesh Maled India 4 17 0.2× 34 0.4× 11 0.5× 22 3.7× 9 68
L. Martinelli Italy 3 31 0.4× 19 0.3× 5 0.2× 2 0.3× 3 1.0× 8 39
Mwashungi Ally Tanzania 3 19 0.2× 14 0.2× 10 0.4× 2 0.3× 1 0.3× 7 27
Jackie Droste United Kingdom 4 44 0.6× 48 0.6× 1 0.0× 3 0.5× 9 49
Alessia Campagna Italy 4 7 0.1× 22 0.3× 15 0.6× 3 1.0× 11 51
Loubna Majhadi France 3 13 0.2× 9 0.1× 7 0.3× 2 0.7× 5 20
Catherine Ogilvie United Kingdom 3 20 0.3× 23 0.3× 12 2.0× 4 1.3× 5 32
I-Ming L. Chen United States 4 6 0.1× 22 0.3× 10 0.4× 1 0.3× 7 32

Countries citing papers authored by C. Ressayre-Djaffer

Since Specialization
Citations

This map shows the geographic impact of C. Ressayre-Djaffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ressayre-Djaffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ressayre-Djaffer more than expected).

Fields of papers citing papers by C. Ressayre-Djaffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Ressayre-Djaffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ressayre-Djaffer. The network helps show where C. Ressayre-Djaffer may publish in the future.

Co-authorship network of co-authors of C. Ressayre-Djaffer

This figure shows the co-authorship network connecting the top 25 collaborators of C. Ressayre-Djaffer. A scholar is included among the top collaborators of C. Ressayre-Djaffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Ressayre-Djaffer. C. Ressayre-Djaffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Cappellini, Maria Domenica, Mohamed Béjaoui, Leyla Ağaoğlu, et al.. (2005). Patient Satisfaction with Deferasirox (Exjade®, ICL670) an Oral Form of Chelation Therapy Versus Deferoxamine an Infused Chelation Therapy.. Blood. 106(11). 2704–2704. 12 indexed citations
3.
Gattermann, Norbert, Peter L. Greenberg, J. Maertens, et al.. (2005). P-113 The efficacy and tolerabilityof ICL670, a once-daily oral iron chelator, in patients with myelodysplastic syndrome (MDS) and iron overload. Leukemia Research. 29. S67–S67. 11 indexed citations
6.
Angelucci, Emanuele, Bruno Turlin, Duran Canatan, et al.. (2005). Iron Chelation Therapy with Deferasirox (Exjade®, ICL670) or Deferoxamine Is Effective in Reducing Iron Overload in Patients with Advanced Fibrosis and Cirrhosis.. Blood. 106(11). 2696–2696. 6 indexed citations
7.
Vichinsky, Elliott, Roland A. Fischer, Zahra Pakbaz, et al.. (2005). Satisfaction and Convenience of Chelation Therapy in Patients with Sickle Cell Disease (SCD): Comparison between Deferasirox (Exjade®, ICL670) and Deferoxamine (DFO).. Blood. 106(11). 2334–2334. 8 indexed citations
8.
Cappellini, Maria Domenica, Mohamed Béjaoui, Silverio Perrotta, et al.. (2004). Phase III Evaluation of Once-Daily, Oral Therapy with ICL670 (Exjade®) Versus Deferoxamine in Patients with β-Thalassemia and Transfusional Hemosiderosis.. Blood. 104(11). 3619–3619. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026